Partnerships

Osentia Affiliates

We Are Recruiting To Our Professional Partnership Programme.

Opportunities exist with suitably placed individuals and organisations for Distribution, Product Integration Collaborations and Affiliate Partnerships. Please get in touch, let's get the conversation going.

500

100

Awards

Osentia

What we do

Osentia empowers Clinicians with a non-invasive, accessible, and personalized method to assess fracture risk, making it a valuable tool in proactive bone health management strategies. For Persons of Influence among Health, Wellness and Awareness Communities, such as Menopause campaigners, Osentia presents an opportunity to educate their followers to empower themselves against what is often referred to as the "Silent Killer".
Osentia’s combination of non-invasive sampling, advanced spectroscopic analysis, personalised risk profiling, and user-friendly design positions it as a distinctive and valuable resource in the early detection and management of bone health issues.
Supported by studies showing the correlation with fracture risk and bone degradation markers, Osentia can identify patients at risk of fragility fractures before significant bone density loss occurs, enabling earlier intervention.
All from a simple nail clipping.

Partnerships

Why Health and Wellbeing Professionals Should Partner with the Osentia Test:

Non-Invasive and Convenient

• Requires only a small fingernail or toenail clipping.
• No radiation exposure.
• At-home sample collection increases accessibility and compliance.

Early Detection of Fracture Risk

• Detects changes in bone health before significant density loss.
• Supports earlier intervention and preventive strategies.
• Particularly useful for asymptomatic patients or those with undiagnosed low bone density.

Personalised Risk Assessment and Tailored Results

• Painless and easy to understand for patients.
• Results can spark conversations around lifestyle, diet, exercise, and supplementation.
• Enables tailored treatment and monitoring plans.
• Enhances patient commitment to long-term bone health.

Clinically Validated Tool

• Supported by research correlating nail keratin analysis with bone degradation.
• Integrates spectroscopic measurements of a stable bio marker with clinical risk factors.
• Suitable for patients unable or unwilling to undergo hospital-based scans. A complementary or alternative option when DXA scans are unavailable or undesirable.
• Ideal for triage and preventive screenings, especially in women 50+, post-menopausal patients, and those with family history or previous medical conditions.
• Effective for secondary prevention in patients with prior fractures and post intervention surveillance.